Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9310941 | 0.91 | AGTR1 (0.51) | AGTR1 | |
| SCHEMBL8549032 | 0.89 | AGTR1 (0.40) | AGTR1 | |
| SCHEMBL9312340 | 0.89 | AGTR1 (0.54) | AGTR1 | |
| SCHEMBL9860039 | 0.87 | AGTR1 (0.58) | AGTR1 | |
| SCHEMBL9662706 | 0.86 | AGTR1 (0.51) | AGTR1 | |
| SCHEMBL9694909 | 0.86 | AGTR1 (0.64) | AGTR1AGTR2 | |
| SCHEMBL9308702 | 0.86 | AGTR1 (0.57) | AGTR1 | |
| SCHEMBL9859950 | 0.85 | AGTR1 (0.61) | AGTR1 | |
| SCHEMBL27350911 | 0.84 | AGTR1 (0.46) | AGTR1 | |
| SCHEMBL9714907 | 0.83 | AGTR1 (0.60) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0514198-B1 | 1H-Imidazol-1-yl-methyl benzofuran derivatives with the imidazolyl moiety being substituted by a cycloalkyl group | GLAXO GROUP LTD (GB) | 1998-08-05 | — | — | EP | disclosed |
| US-5498722-A | HYPOTENSIVES | GLAXO GROUP (GB) | 1996-03-12 | — | — | US | disclosed |
| WO-1992020674-A1 | 1H-IMIDAZOL-1-YL-METHYL BENZOFURAN DERIVATIVES, WITH THE IMIDAZOLYL MOIETY BEING SUBSTITUTED BY A CYCLOALKYL GROUP | GLAXO GROUP LIMITED (GB) | 1992-11-26 | — | — | WO | disclosed |
| EP-0514198-A1 | 1H-Imidazol-1-yl-methyl benzofuran derivatives with the imidazolyl moiety being substituted by a cycloalkyl group | GLAXO GROUP LIMITED (GB) | 1992-11-19 | — | — | EP | disclosed |